Southern Specialty Research | Flowood, MS

Research site

About

Advancing medicine, improving lives

Location

803 Liberty Road, Flowood, Mississippi, United States of America

Website

https://southernspecialtyresearch.org/

Site insights

Top conditions

Top treatments

Concizumab

Mitapivat

Crizanlizumab

AG-348

Anumigilimab

Crovalimab

Rilzabrutinib

CSL324

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Wendy Thomson

Verified by this site

Active trials

4 of 6 total trials

A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)

This clinical trial is a Phase 2/3 study that will determine the recommended dose of mitapivat and evaluate the efficacy and safety of mitapivat in s...

Active, not recruiting

Sickle Cell Disease

Other: Mitapivat-matching placebo

Drug: Mitapivat

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

A phase III, multi-center, randomized, placebo-controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo...

Enrolling

Sickle Cell Disease

Biological: Crizanlizumab

Drug: Placebo

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

This is a phase 2a, global, multicenter, randomized, double-blind, placebo-controlled study investigating the safety of anumigilimab administered sub...

Enrolling

Sickle Cell Disease

Biological: Anumigilimab

Drug: Placebo

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease (LIBRA)

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, flexible-adaptive, group-sequential study (Part A), followed by...

Enrolling

Sickle Cell Disease

Drug: Rilzabrutinib

Drug: Placebo